Advances in neuroprotection research for neurodegenerative diseases.
D000818:Animals; D018491:Dopamine Agonists / Q000627:therapeutic use; D004958:Estradiol / Q000031:analogs & derivatives; D006801:Humans; D019636:Neurodegenerative Diseases / Q000517:prevention & control*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D009498:Neurotoxins / Q000009:adverse effects; D018384:Oxidative Stress / Q000187:drug effects; D010293:Pargyline / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011437:Propylamines / Q000627:therapeutic use
D018491:Dopamine Agonists; D018696:Neuroprotective Agents; D009498:Neurotoxins; D011437:Propylamines; C009054:propargylamine; D004958:Estradiol; D010293:Pargyline